News
Global Cannabis News & Analysis | Business of Cannabis
News · page 21
- Events
Business of Cannabis: New York 2025 – Key Takeaways
Business of Cannabis: New York 2025 arrived at a crucial moment not just for the local cannabis industry, but for the entire state.
- Industry Trends
Why Cannabis Stocks Are So Volatile: How Policy, Capital and Hype Shaped a Perpetual Rollercoaster
From the euphoric highs of 2018’s ‘green rush’ to the sharp corrections and structural stasis that have followed, cannabis equities have been among the most volatile financial assets since they first appeared on global markets.
- Medical Cannabis
Cannabis Group Cannim Collapses: UK Clinics Pause, Creditors Pursue Millions
Cannim Group Pty, the international medical cannabis company with operations spanning the UK, Australia, the US and Canada, has entered voluntary administration.
- Industry Trends
New Data Shows UK Medical Cannabis Industry Still Has a Gender Problem
Despite being the second-largest and one of the most mature medical cannabis markets in Europe, the UK still falls well behind its peers in one key area, data.
- Industry Trends
Why is No One Talking About Germany’s Oversupply Problem?
Germany’s telemedicine-fuelled expansion has driven the value of its medical cannabis market up by hundreds of millions of euros in just less than two years.
- Prescribers & Clinics
High-THC Leads Growth as Australia Tightens TGA Prescribing Rules
The medical cannabis industries in Australia and New Zealand are continuing to evolve rapidly, with both markets showing signs of maturation, regulatory recalibration, and expanding export ambitions, according to new data.
- Hemp Industry
What the US Government Shutdown Means for Cannabis Reform
President Donald Trump has called on Senate Republicans to invoke the so-called ‘nuclear option’ to break the month-long government shutdown, a move that would eliminate the long-standing 60-vote filibuster rule and allow other legislation to pass by a simple majority.
- Industry Trends
New York Cannabis Retailers Push Back on $30m Product Recall and ‘Rent-a-Licence’ Scandal
Oregon-based edibles company Grön has weighed in on the ongoing controversy surrounding New York’s so-called ‘rent-a-licence’ scandal.
- Medical Cannabis
Germany Expands Its Medical Cannabis Import Cap as Australia Moves to Cut Back
Australia and Germany are moving in opposite directions on medical cannabis imports, as both scramble to deal with the runaway growth of their medical cannabis markets.
- Industry Trends
Early Results From Züri Can Pilot Bolster Case for Switzerland’s Federal Legalisation
Zurich’s flagship adult-use cannabis trial, Züri Can, could now run until 2028 after city officials applied this week to extend the project by two years, citing strong early results in reducing illicit sales and promoting safer consumption.
- Medical Cannabis
ACCM Launches National Partnerships to Expand Medical Cannabis Access and Insurance Coverage
The American Council of Cannabis Medicine (ACCM) has announced the launch of a new nationwide initiative with major insurers, healthcare systems, and associations to expand affordable access to medically guided cannabis treatment across the United States.
- UK & Europe
‘Significant Variation in Standards’ Found Across UK Medical Cannabis Pharmacies as ACMD Review Call Closes
The Advisory Council on the Misuse of Drugs (ACMD) has closed its latest call for evidence into the impact of medical cannabis legalisation, in what will mark the most comprehensive review of the UK’s cannabis-based products for medicinal use (CBPM) framework since it was introduced in 2018.
